Inspection·October 9, 2025

F 0656 Level of Harm - Minimal harm or potential for actual harm meeting was late. Interview on 09/30/25 at 7:44 A.M., via phone with LPN #605 confirmed care plan meetings were to be done quarterly. LPN #605 confirmed Resident #134 did not have a care plan meeting done timely and didn't know why. Review of the undated facility policy titled Plan of Care Overview revealed attendees will sign and date care plan meeting agendas/documents. This deficiency is an incidental finding identified during the complaint investigation. Residents Affected - Few FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 365779 If continuation sheet Page 2 of 6 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 365779 B. Wing A. Building (X3) DATE SURVEY COMPLETED 10/09/2025 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Wyant Woods Healthcare Center 200 Wyant Rd Akron, OH 44313 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)

F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review, interviews, laboratory test reviews, hospital medical records review, pharmacy reviews and facility policy review, the facility failed to ensure the monthly pharmacy reviews recommended Resident #117's seizure medications were monitored with laboratory tests timely to prevent high/critical/toxic levels. This affected one resident (#117) out of three residents reviewed for medication monitoring. The facility census was 162. Findings include:Review of the medical record for Resident #117 revealed an admission date of 11/25/21. Diagnoses included hemiplegia and hemiparesis following cerebral infarction affecting the right dominant side, epilepsy, encephalopathy, impulse disorder and mood affective disorder. Resident #117 had a guardian since 2015. Review of the laboratory for Phenobarbital done at the facility for Resident #117 revealed a date of 01/24/25. The Phenobarbital level was 21 (normal range 10 to 40 micrograms per milliliter UG/ML). Review of the laboratory results dated [DATE] revealed the Levetiracetam (Keppra) (seizure medication) was high at 76, with normal range 6.00 to (-) 46.00 micrograms per milligram (ug/ml), Phenobarbital (seizure medication) was 23 ug/ml within normal limits (WNL) of 10-40 ug/ml, and Carbamazepine (Tegretol) (seizure medication) was 7.6 ug/ml WNL of 4-12 ug/ml. A repeat lab was done on 01/31/25 and revealed Levetiracetam (Keppra) was 30 ug/ml which was WNL, and Phenobarbital was 21 ug/ml which was WNL. There were no further laboratory tests done for seizure medication monitoring through the start of the investigation on 09/24/25. Review of the Minimum Data Set (MDS) 3.0 assessment dated [DATE] revealed Resident #117 had intact cognition, with a Brief Interview for Mental Status (BIMS) score of 13 out of 15. Resident #117 was dependent on staff for showers, lower dressing, footwear and personal hygiene and required substantial assistance for toileting, upper dressing, and oral hygiene and set up assistance for eating. Review of the May and August 2025 Medication Administration Records (MARs) revealed an order Carbamazepine Extended Release (ER) (Tegretol) (anticonvulsant) 200 mg po BID for seizures (start date 12/28/23 and discontinue date of 07/28/25) on 07/28/25 the Tegretol 200 mg was re-ordered one tablet BID for seizures/epilepsy, an order for Levetiracetam (Keppra) (anticonvulsant) 1000 milligrams (mg) one tablet by mouth (po) two times daily (BID) for seizures (start date 12/28/23), Gabapentin 600 mg (anticonvulsant) one tablet po at bedtime (start date 08/06/24) and 600 mg two tablets po in the morning (start date 08/07/24), Dilantin (anticonvulsant) 100 mg one capsule po three times daily (TID) for seizures (start 01/27/25), Phenobarbital (anticonvulsant) 64.8 mg give 1 tablet po BID for convulsions (start date 04/07/25), and Divalproex Sodium capsule delayed release Sprinkle (Depakote) (anticonvulsant) 125 mg one capsule po TID (start 07/06/25). Review of the pharmacy recommendations from 06/01/25 to 08/25/25 revealed the pharmacist failed to identify the need for lab tests for levels for the anticonvulsants that Resident #117 was receiving. Review of the progress note dated 08/25/25 at 6:32 P.M. revealed a change in condition for Resident #117. Resident #117 had a decrease in food and fluid intake and a functional decline with worsening function and mobility. The resident's diet was downgraded to a puree diet with thickened liquids due to the concern of aspiration, and the resident was no longer able to assist with his personal care as he used to before and was now requiring total care. Review of the progress note dated 08/25/25 at 6:48 P.M. revealed Resident #117's guardian, unit manager, and physician were notified of the change in condition. Review of progress note dated 08/26/25 at 11:11 A.M. revealed Resident #117 was tested for Respiratory Syncytial Virus/Coronavirus Disease of 2019 (RSV/COVID) due to related symptoms, and the results were negative. Plan of care continued, and all parties notified per change in condition (CIC) form. Review of the progress note dated 08/26/25 at 1:30 P.M. revealed therapy notified the nurse that the resident (continued on next page) FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 365779 If continuation sheet Page 3 of 6 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 365779 B. Wing A. Building (X3) DATE SURVEY COMPLETED 10/09/2025 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Wyant Woods Healthcare Center 200 Wyant Rd Akron, OH 44313 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)

F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few was having a hard time eating. The nurse notified the physician, and he ordered to send the resident to the hospital for an evaluation. The Director of Nursing (DON) and guardian were notified. Review of the progress note dated 08/26/25 at 1:36 P.M. revealed Resident #117 was sent to hospital via 911 for altered mental status and poor intake of food and liquids. Resident #117 appeared to be lethargic and not swallowing well. Emergency Medical Services (EMS) arrived at 1:45 P.M. All notifications were made to include the physician, DON, unit manager, and guardian of the transfer to the hospital for evaluation. Review of the progress note dated 08/26/25 at 4:35 P.M. revealed Resident #117 was admitted to the hospital with diagnoses of altered mental status (AMS) and adult failure to thrive. All required parties were notified. Review of the progress noted dated 08/26/25 at 4:36 P.M. revealed Resident #117's guardian was notified of the hospital transfer. Review of the progress note dated 08/26/25 at 5:53 P.M. revealed Resident #117's guardian was updated on the resident's status at the hospital. Review of the hospital medical records dated 08/26/25 revealed Resident #117 was admitted to the hospital with diagnosis of AMS. Review of the hospital medical laboratory records dated 08/26/25 at 5:48 P.M. revealed Resident #117's Phenobarbital results were 55.9 ug/ml which was a HIGH ALERT, (meaning the Phenobarbital level in the person's blood is outside the normal therapeutic range and has reached a potentially toxic level, further because phenobarbital is a high-alert medication with a narrow therapeutic window, a critical result requires immediate attention from a healthcare provider to prevent serious harm. A High-Alert Phenobarbital lab value is a red flag indicating a potentially life-threatening drug level that requires an immediate and serious response from medical professionals.) The normal range for Phenobarbital is 15.0 to 40.0 ug/ml. A high level of Phenobarbital in the blood can cause serious complications including significant drowsiness and confusion, dangerously slowed or stopped breathing, slurred speech, poor coordination and coma or death. Review of the hospital medical laboratory records dated 08/27/25 at 11:15 P.M. revealed Resident #117's Phenobarbital results were 49.9 ug/ml which was considered HIGH. Review of the hospital medical records revealed Neurology held Resident #117's Phenobarbital for a short period of time due to the elevated levels. Review of the progress note dated 08/28/25 at 1:21 P.M. revealed Resident #117's guardian called Former Assistant Director of Nursing (ADON) #900, who is no longer at the facility, and stated she no longer wanted the facility Psychiatric Physician #805 to follow the resident due to concerns of polypharmacy. Resident 117's guardian further stated she only wanted Physician #815 to follow the resident. Psychiatric Physician #805 was notified and agreed to no longer follow Resident #117 as requested by the guardian. Physician #815 was notified and agreed to follow Resident #117 to include psychiatric medication. Review of the progress note dated 08/31/25 at 1:29 P.M. revealed Resident #117 returned to the facility. Physician #815 and guardian notified of return to facility. Review of the pharmacy recommendation review, form titled Note To Attending Physician with Medical Regimen Review (MMR), dated 09/17/25 by Pharmacist #810, revealed Resident #117 is ordered Tegretol, Phenobarbital, and Keppra, all seizure medications. Request to order labs to include Complete Blood Count with differential (CBC w/Diff), Phenobarbital, Carbamazepine (Tegretol), and Levetiracetam (Keppra) every (Q) six (6) months. The form was not addressed by the physician. The physician prescriber response of agree, disagree, or other was left blank, and there was no signature of completion as of 09/29/25. Interview on 09/25/25 at 1:55 P.M. with Corporate Nurse #800 confirmed there was no labs ordered for the seizure medications. Corporate Nurse #800 confirmed the last lab done for seizure medication monitoring in the facility was 01/27/25. Corporate Nurse #800 confirmed the pharmacy recommendation form dated 09/17/25 was not completed. Corporate Nurse #800 reported the facility had 30 days to address the pharmacy recommendations. Interview on 09/25/25 at 1:58 P.M. with Pharmacist #810 (continued on next page) FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 365779 If continuation sheet Page 4 of 6 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 365779 B. Wing A. Building (X3) DATE SURVEY COMPLETED 10/09/2025 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Wyant Woods Healthcare Center 200 Wyant Rd Akron, OH 44313 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)

F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few FORM CMS-2567 (02/99) Previous Versions Obsolete confirmed residents on seizure medications should have labs done at least three times a year if stable. Pharmacist #810 is the pharmacist that did the monthly recommendations. Interview on 09/25/25 at 2:22 P.M. with Physician #815 confirmed for residents on medications for seizures, to include Resident #117 should have labs checked at least a couple times a year. Interview on 09/29/25 at 9:54 A.M. with the DON confirmed there was no lab ordered to monitor Resident #117's three seizure medication since January 2025 prior to the resident being admitted to the hospital on [DATE] with a HIGH ALERT Phenobarbital level. The DON confirmed the pharmacy recommendation form dated 09/17/25 requested the physician to order labs for seizure medications every six months was not addressed. Review of facility policy, Medication Regimen Review, undated, revealed the monthly medication review will be performed by a licensed pharmacist according to federal and state regulations meeting current standards of practice and to review and report any identified medication irregularities in accordance with this policy. The pharmacist will report any irregularities to the attending medical practitioner and DON and these reports must be acted upon in a timely manner that meets the needs of the residents. DON will be responsible for addressing all medication irregularity reports with the medical practitioner in a manner that meets the needs of the resident. Urgent or significant medication irregularity is communicated the day it is observed and non-urgent irregularities within 72 hours or their last scheduled consultation visit for the month or sooner. This deficiency represents non-compliance investigated under Complaint Number 2603626. Event ID: Facility ID: 365779 If continuation sheet Page 5 of 6 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 365779 B. Wing A. Building (X3) DATE SURVEY COMPLETED 10/09/2025 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Wyant Woods Healthcare Center 200 Wyant Rd Akron, OH 44313 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)

F 0760 Ensure that residents are free from significant medication errors. Level of Harm - Minimal harm or potential for actual harm **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review, interviews and facility policy review, the facility failed to ensure Resident #117's antibiotic medication was administered according to the physician orders. This affected one resident (#117) out of four residents reviewed for medications. The facility census was 162. Findings include:Review of the medical record for Resident #117 revealed an admission date of 11/25/21. Diagnoses included hemiplegia and hemiparesis following cerebral infarction affecting the right dominant side, epilepsy, encephalopathy, impulse disorder and mood affective disorder. Resident #117 had a guardian since 2015. Review of the Minimum Data Set (MDS) 3.0 assessment dated [DATE] revealed Resident #117 had intact cognition, with a Brief Interview for Mental Status (BIMS) score of 13 out of 15. Resident #117 was dependent on staff for showers, lower body dressing, footwear and personal hygiene and required substantial assistance for toileting, upper body dressing, and oral hygiene and set up assistance for eating. Review of the chest x-ray report dated 08/18/25 at 10:14 P.M. revealed resident #117 had left lower lobe atelectasis/infiltrate. Review of the physician's order dated 08/20/25 revealed Resident #117 was ordered Levofloxacin (antibiotic) 250 milligram (mg) give three tablets, to total 750 mg, by mouth (PO) one time a day for infection for five days at 7:00 A.M. The order was discontinued on 08/20/25 after administering the dose. Review of the physician's order dated 08/21/25 revealed Resident #117 was ordered Levofloxacin 250 mg give three tablets, to total 750 mg, by mouth (PO) one time a day for pneumonia until 08/26/25 to start on 08/21/25 at 7:00 A.M. Review of the Medication Administrator Records (MAR) for August 2025 revealed Levofloxacin 250 mg, three tablets, totaling 750 mg was administered on 08/20/25 and 08/21/25 per the physician's order. On 08/22/25 and 08/23/25 the MAR had a number nine and the nurses initials. Review of the progress notes for 08/22/25 revealed the Levofloxacin 250 mg, three tablets, totaling 750 mg was on order. There was no documented evidence that the physician was notified. Review of the progress notes for 08/23/25 revealed the Levofloxacin 250 mg, three tablets, totaling 750 mg were not available. There was no documented evidence that the physician was notified. Interview on 10/07/25 at 3:45 P.M. with Corporate Nurse #800 confirmed Resident #117 did not receive his antibiotic medication as ordered on 08/22/25 and 08/23/25. Corporate Nurse #800 reported the medication was not available. Interview on 10/09/25 at 9:19 A.M. with Registered Nurse (RN)# 693 confirmed Levofloxacin for pneumonia was not administered on 08/22/25 and 08/23/25 due to the medication not available from pharmacy. RN #693 reported she checked in the Pixus machine, which usually had the medication, but it was out. RN #693 reported she contacted the pharmacy, and they were supposed to have it drop shipped, but it never came. RN #693 confirmed that there was no documented evidence that the physician was notified that the medication was not available to administer to Resident #117. Review of the facility policy titled Medication Administration, dated 2013, revealed to administer medications only as prescribed by the provider. This deficiency is an incidental finding identified during the complaint investigation. Residents Affected - Few FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 365779 If continuation sheet Page 6 of 6